A genetically engineered bacterium with high yield of l-valine and method for producing l-valine by fermentation

A technology of genetically engineered bacteria and valine, applied in the field of microorganisms, can solve the problems of unbalanced coenzyme supply and demand, low sugar-acid conversion rate, etc.

Active Publication Date: 2021-05-25
TIANJIN UNIV OF SCI & TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] One of the purposes of the present invention is to provide a new idea for the construction of L-valine engineering bacteria, which solves the problems of unbalanced supply and demand of coenzyme and low conversion rate of sugar and acid in the synthesis and metabolism of L-valine, and obtains through directional transformation A Genetically Engineered Strain of Escherichia coli with High Production of L-Valine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A genetically engineered bacterium with high yield of l-valine and method for producing l-valine by fermentation
  • A genetically engineered bacterium with high yield of l-valine and method for producing l-valine by fermentation
  • A genetically engineered bacterium with high yield of l-valine and method for producing l-valine by fermentation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] The efficient L-valine production strains VXR01, VXR02, and VXR03 were constructed, and the gene editing method used was referred to the literature (Li Y, Lin Z, Huang C, et al. Metabolic engineering of Escherichia coli using CRISPR–Cas9meditated genome editing. Metabolic engineering, 2015 ,31:13-21.), the specific method is as follows:

[0039] 1 The acetolactate synthase coding gene alsS was integrated into the pseudogene site ydeU to construct strain VXR01

[0040] 1.1 Preparation of recombinant DNA fragments

[0041] The alsS gene was integrated into the ydeU pseudogene locus. Using the genome of Bacillus subtilis B.subtilis 168 as a template, the gene alsS (NCBI-Protein ID: NP_391482.2) was amplified by PCR; using the genome of Escherichia coli W3110 as a template, the upstream and downstream homology arm fragments of ydeU (primer UP -ydeU-S, UP-ydeU-A; DN-ydeU-S, DN-ydeU-A); promoter P trc Designed in the downstream primer of the upstream homology arm and the u...

Embodiment 2

[0103] Shake flask fermentation of strains VXR02 and VXR05:

[0104] Slant culture: Streak inoculation of -80°C preserved strains on the activated slant, culture at 37°C for 12 hours, and subculture twice;

[0105] Shake flask seed culture: use the inoculation loop to scrape two rings of slant seeds and inoculate them into a 500mL Erlenmeyer flask containing 30mL of seed medium, culture at 37°C and 200rpm for 8-10h;

[0106] Shake flask aerobic fermentation: Inoculate 10-15% of the inoculum into a 500mL Erlenmeyer flask with fermentation medium (final volume is 30mL), culture at 37°C with shaking at 200r / min, maintain pH by adding ammonia water during fermentation At 6.7-7.0, add 60% (m / v) glucose solution to maintain the fermentation, and the fermentation period is 24h;

[0107] Aerobic-anaerobic two-stage fermentation: Inoculate 10-15% of the inoculum into a 500mL Erlenmeyer flask with fermentation medium (final volume is 30mL), 37°C, 200r / min shaking culture; after 12-16h,...

Embodiment 3

[0115] 5L fermenter fermentation of strains VXR02 and VXR05:

[0116] Aerobic fermentation: Activate the strains on the slope for two generations, insert 15-20% of the inoculum into the fermentation medium, and start fermentation. During the fermentation process, the pH is controlled to be stable at about 6.7, the temperature is maintained at 35°C, and the dissolved oxygen is controlled at 25-30%; when the glucose in the medium is consumed, add 80% (m / v) glucose solution to maintain the glucose concentration in the fermentation medium at 0.1-5g / L; the fermentation period is 40h;

[0117] Aerobic-anaerobic two-stage fermentation: Activate the strains on the slope for two generations, insert 15-20% of the inoculum into the fermentation medium, and start fermentation. During the fermentation process, the pH is controlled to be stable at about 6.7, and the temperature is maintained at 35°C , control dissolved oxygen at 25-30%; when the glucose in the medium is consumed, add 80% (m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a high-yield L-valine genetically engineered bacterium, starting from Escherichia coli W3110, integrating the acetolactate synthase gene alsS of Bacillus subtilis on its genome and making it strongly expressed; and on its genome Integrated Escherichia coli ppGpp 3′-pyrophosphate hydrolase mutant R290E / K292D gene spoT and made it strongly expressed; and knocked out lactate dehydrogenase gene ldhA, pyruvate formate lyase I gene pflB and fumaric acid in its genome The genes frdA, frdB, frdC, frdD of the four subunits of reductase; and the branched-chain amino acid transaminase gene ilvE of Escherichia coli is replaced by the leucine dehydrogenase gene bcd of Bacillus subtilis; The isomeroreductase gene ilvC was replaced by the gene encoding the mutant L67E / R68F / K75E. The invention also improves the L-valine fermentation method, adopts two-stage dissolved oxygen control, and improves the L-valine production rate and sugar-acid conversion rate.

Description

technical field [0001] The invention relates to the field of microorganisms, genetic engineering and fermentation engineering, in particular to a genetically engineered bacterium with high yield of L-valine and its application. Background technique [0002] L-valine (L-valine) is a branched chain amino acid (Branched chain amino acids, BCAA), widely used in food, medicine, cosmetics and feed and other fields. As an essential amino acid for the human body, it can not only promote muscle formation, strengthen liver function, and reduce muscle fatigue, but also serve as an intermediate in the synthesis of immune antibiotics and drugs, and it can also promote skin glial protein synthesis. In recent years, as an important dietary amino acid variety, the demand for L-valine continues to increase. [0003] The synthetic branch of L-valine uses pyruvate as the immediate precursor. Pyruvate undergoes a four-step reaction catalyzed by acetohydroxyacid synthase AHAS, acetohydroxyacid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/21C12N15/70C12P13/08C12R1/19
CPCC12P13/08C12N9/1022C12Y202/01006C12N9/14C12N9/0016C12N9/0004C12Y306/01005C12Y104/01009C12R2001/19C12N15/52C12R2001/125C12N15/70
Inventor 谢希贤刘晓倩郝亚男门佳轩刘益宁李旋田道光文晨辉熊博
Owner TIANJIN UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap